Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 20;3(12):e333.
doi: 10.1097/TXD.0000000000000749. eCollection 2017 Dec.

Pulmonary Allograft Versus Host Disease

Affiliations

Pulmonary Allograft Versus Host Disease

David W Dai et al. Transplant Direct. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Figures

FIGURE 1
FIGURE 1
A macular rash on bilateral soles.
FIGURE 2
FIGURE 2
Bilirubin trend posttransplantation. Arrow indicates initiation of high dose corticosteroids (posttransplant day 80).

References

    1. Burdick JF, Vogelsang GB, Smith WJ, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med. 1988;318:689–691. - PubMed
    1. Assi MA, Pulido JS, Peters SG, et al. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007;21:1–6. - PubMed
    1. Ataya A, Biswas A, Chandrashekaran S, et al. A 48-year-old man with leukopenia, jaundice, and skin rash after lung transplantation. Chest. 2016;150:e167–e170. - PubMed
    1. Chau EM, Lee J, Yew WW, et al. Mediastinal irradiation for graft-versus-host disease in a heart-lung transplant recipient. J Heart Lung Transplant. 1997;16:974–979. - PubMed
    1. Fossi A, Voltolini L, Filippi R, et al. Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids. J Heart Lung Transplant. 2009;28:508–510. - PubMed